Chronic pancreatitis in acute setting - Nursing Case Study
Pathophysiology
• Primary mechanism: Chronic pancreatitis involves recurrent inflammation leading to irreversible damage of pancreatic tissue. This results in fibrosis, which impairs both exocrine and endocrine functions, causing malabsorption and potential diabetes.
• Secondary mechanism: Persistent inflammation and fibrosis obstruct pancreatic ducts, leading to the buildup of digestive enzymes within the pancreas. This can cause auto-digestion of pancreatic tissue, exacerbating inflammation and damage.
• Key complication: In an acute setting, blockage of ducts and enzyme buildup can lead to acute exacerbations, causing severe abdominal pain, nausea, and potentially life-threatening complications like pancreatic necrosis or pseudocyst formation.
Patient Profile
Demographics:
45-year-old male, construction worker
History:
• Key past medical history: Chronic pancreatitis diagnosed 3 years ago, history of alcohol use disorder, type 2 diabetes
• Current medications: Pancrelipase, insulin, omeprazole
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe abdominal pain
• Key symptoms: Nausea, vomiting, weight loss, steatorrhea
• Vital signs: Temperature 101.3°F, heart rate 110 bpm, blood pressure 98/65 mmHg, respiratory rate 22 breaths per minute, oxygen saturation 94% on room air
Section 1
As the healthcare team continues to monitor the patient, initial assessment findings reveal additional concerns. On examination, the patient's abdomen is distended with notable tenderness in the epigastric region. Bowel sounds are hypoactive, suggesting reduced gastrointestinal motility. Laboratory tests show elevated serum amylase and lipase levels, consistent with acute exacerbation of pancreatitis. Electrolyte panels indicate hyponatremia and hypokalemia, likely due to ongoing vomiting and malabsorption. The complete blood count (CBC) reveals leukocytosis, suggesting an inflammatory or infectious process.
Given the patient's history of alcohol use disorder and chronic pancreatitis, the healthcare team considers potential complications like pancreatic pseudocyst formation. An abdominal CT scan is ordered, revealing a 5 cm fluid-filled cystic structure in the tail of the pancreas, indicative of a pseudocyst. This finding explains the persistent abdominal pain and could potentially cause further complications such as rupture or infection if not addressed promptly.
The patient's oxygen saturation has decreased to 90% on room air, and he is now tachypneic with a respiratory rate of 28 breaths per minute, indicating possible respiratory compromise. This change in status prompts the initiation of supplemental oxygen therapy and a re-evaluation of his pain management regimen. The team discusses the possibility of endoscopic or surgical intervention for the pseudocyst, depending on symptom progression and the patient's overall stability. These findings necessitate close monitoring and prompt intervention to prevent a decline in the patient’s condition, highlighting the need for ongoing assessment and management adjustments.
Section 2
As the healthcare team continues to address the patient's condition, they focus on the change in his respiratory status, which has become a pressing concern. Despite the initiation of supplemental oxygen therapy, the patient's oxygen saturation remains at 92% with a persistent respiratory rate of 28 breaths per minute. Auscultation reveals diminished breath sounds in the lower lung fields, suggesting the development of atelectasis or possibly a pleural effusion due to the inflammatory process. The team decides to perform a chest X-ray to further investigate the cause of the respiratory compromise. The imaging reveals bilateral pleural effusions, likely secondary to the systemic inflammatory response associated with the acute exacerbation of pancreatitis.
In response to these findings, the healthcare team prioritizes optimizing the patient's respiratory status. They initiate a trial of diuretics to manage the pleural effusions and increase oxygen delivery to high-flow nasal cannula to better support the patient's oxygenation needs. The patient's electrolyte imbalances are addressed with intravenous potassium and sodium supplementation to correct the hyponatremia and hypokalemia, as these could further compromise cardiac and muscular function, potentially exacerbating the respiratory compromise. The team remains vigilant for signs of fluid overload or worsening respiratory distress, understanding that prompt recognition and management of these complications are critical to stabilizing the patient.
As the patient is closely monitored, the team discusses the need for potential drainage of the pleural effusions if the patient's respiratory status does not improve. Additionally, they consider the timing of intervention for the pancreatic pseudocyst, weighing the risks and benefits of surgical versus endoscopic management. The patient's history of alcohol use prompts the healthcare team to engage in discussions about long-term management and support for alcohol cessation, recognizing that addressing this underlying issue is essential for preventing further exacerbations and complications in the future.
Section 3
As the healthcare team continues to monitor the patient's response to interventions, they observe a change in his status. Over the next 12 hours, the patient's respiratory rate decreases to 22 breaths per minute, and his oxygen saturation improves to 95% on high-flow nasal cannula. However, the patient begins to develop new symptoms, including increased abdominal pain and distension, along with a low-grade fever of 100.5°F. These changes raise concerns for the development of an infected pancreatic pseudocyst or worsening systemic inflammation.
Laboratory investigations reveal a white blood cell count of 16,000/mm³, indicating a potential infectious process. Serum amylase and lipase levels remain elevated, consistent with the ongoing pancreatic inflammation. The patient's renal function is monitored closely, with serum creatinine levels rising slightly to 1.4 mg/dL, suggesting a need to adjust the diuretic therapy to balance fluid management and prevent renal impairment.
The healthcare team decides to order an abdominal CT scan to evaluate the status of the pancreatic pseudocyst and assess for any signs of infection or further complications. The scan reveals an increase in the size of the pseudocyst with evidence of fluid collection, suggesting possible infection. Given these findings, the team considers the need for percutaneous drainage and begins to discuss the possibility of starting broad-spectrum antibiotics to address the suspected infection. Recognizing the complexity of the patient's condition, the team remains focused on closely coordinating care to address both the acute respiratory concerns and the evolving abdominal complications.
Section 4
As the team moves forward with the plan to address the suspected infected pancreatic pseudocyst, they initiate broad-spectrum antibiotic therapy, targeting a range of possible pathogens. The patient is started on intravenous piperacillin-tazobactam, and his progress is monitored closely. Over the next 24 hours, the patient's abdominal pain and distension remain significant, and his fever persists, fluctuating between 100.5°F and 101.2°F. His heart rate has increased slightly to 104 beats per minute, and his blood pressure remains stable at 118/76 mmHg. Repeat laboratory tests show a continued elevated white blood cell count of 17,500/mm³, while serum creatinine has stabilized at 1.4 mg/dL, indicating careful fluid balance management.
The decision is made to proceed with percutaneous drainage of the pseudocyst. The intervention is performed under ultrasound guidance, and approximately 150 mL of purulent fluid is aspirated, confirming the presence of an infection. The fluid is sent for culture and sensitivity to identify the causative organism and tailor antibiotic therapy accordingly. Post-procedure, the patient is monitored for any immediate complications, such as bleeding or infection spread. Over the next few hours, his abdominal pain begins to show signs of improvement, and his oxygen saturation remains stable at 96% on high-flow nasal cannula. The healthcare team remains vigilant, recognizing the potential for further complications such as sepsis or acute kidney injury.
The patient's clinical course necessitates ongoing evaluation and adjustment of the treatment plan. The team holds a multidisciplinary meeting to review the latest findings and discuss the next steps. They emphasize the importance of ongoing monitoring of renal function, respiratory status, and potential systemic inflammatory responses. Additionally, they plan to reassess the patient's nutritional needs, considering the impact of chronic pancreatitis on digestion and nutrient absorption. As they await culture results, the team remains proactive in anticipating potential changes in the patient's condition, ready to adapt their approach to ensure comprehensive and effective care.
Section 5
Several days post-procedure, the patient’s condition begins to evolve, highlighting new complications that require the healthcare team's immediate attention. Despite the initial improvement in abdominal pain, the patient develops a sudden increase in respiratory rate to 28 breaths per minute, with oxygen saturation dropping to 92% on high-flow nasal cannula. Auscultation reveals diminished breath sounds in the lower lung fields, and the patient reports increased fatigue and mild confusion. In parallel, his heart rate has risen to 112 beats per minute, and his blood pressure has slightly decreased to 106/68 mmHg, raising concerns about potential hemodynamic instability.
A repeat chest X-ray is ordered and reveals new bilateral pleural effusions, likely secondary to the inflammatory process and fluid shifts associated with the infected pancreatic pseudocyst. Concurrently, the patient's renal function is monitored closely, with serum creatinine subtly increasing to 1.6 mg/dL, suggesting a mild acute kidney injury potentially exacerbated by the ongoing systemic inflammatory response.
The team promptly convenes to address these findings, adjusting the patient's management plan to include diuretic therapy to alleviate fluid overload and improve respiratory function. They also consider revising the antibiotic regimen based on preliminary culture results, which indicate the presence of a resistant strain of Enterococcus species. The focus remains on maintaining hemodynamic stability and optimizing respiratory support, while nutritional support is advanced to include enteral feeding to enhance recovery. The team anticipates the need for further interventions and continues to monitor the patient closely, prepared to respond to any additional changes in his clinical status.